Jubilant Cadista Recalls Valsartan Tablets Due to Potential Excipient Error
Jubilant Cadista Pharmaceuticals is recalling Valsartan tablets because an incorrect grade of excipient may have been used during manufacturing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which indicates a low risk of adverse health consequences. The hazard involves a potential manufacturing error regarding an excipient grade, which is a quality control issue rather than a direct, high-risk contamination or mislabeling of a common allergen.
Plain-English summary
Jubilant Cadista Pharmaceuticals, Inc. is recalling Valsartan Tablets USP, 80 mg, 90-count bottles. The recall involves 9,552 bottles of the medication, which is prescribed for the treatment of high blood pressure. The product was distributed throughout the United States to wholesalers and retailers.
The recall was initiated due to a potential use of an incorrect grade of excipient during the manufacturing process. An excipient is an inactive ingredient added to a drug product to aid in its formulation or stability. The use of an incorrect grade may affect the quality or safety of the medication, although the specific nature of the defect is not detailed in the source text.
Consumers who have this specific product should stop using it and contact their healthcare provider or pharmacist for guidance. The affected product is identified by Lot # VR217013A with an expiration date of 08/2019. The NDC number for the recalled 90-count bottle is 59746-361-90.
The recalled product
- Product
- VALSARTAN (VALSARTAN)
- Brand
- VALSARTAN
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 9,552
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: VR217013A
- Exp. 08/2019
UPCs (8)
- 0359746363321
- 0359746363307
- 0359746361037
- 0359746362034
- 0359746360306
- 0359746360030
- 0359746361303
- 0359746362300
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 4 recalled by Jubilant Cadista Pharmaceuticals, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same brand · VALSARTAN
- ModerateCardinal Health Recalls Valsartan Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- SevereAurobindo Pharma Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Pharma Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
- SevereAurobindo Recalls Valsartan Tablets Due to NDEA Impurity
FDA (Drugs) · 2019-03-27
Same manufacturer · Jubilant Cadista Pharmaceuticals, Inc.
See all →- Moderate
- HighIrbesartan Blood Pressure Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2022-08-03
- HighJubilant Cadista Irbesartan tablets recalled due to failed dissolution
FDA (Drugs) · 2022-08-03
- ModerateFDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
FDA (Drugs) · 2022-04-13
- SevereMeclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
FDA (Drugs) · 2022-04-06
Same hazard · manufacturing error
See all →- HighTRIGEN proximal humeral nails are missing their distal holes
FDA (Devices) · 2026-06-24
- HighStraumann angled custom abutments made from wrong bar material
FDA (Devices) · 2026-04-01
- HighStraumann custom abutments made from wrong bar material after mix-up
FDA (Devices) · 2026-04-01
- HighMedtronic tissue stabilizer recalled after tubing was assembled in reverse
FDA (Devices) · 2026-03-04
- HighDASH COVID and flu tests may give a false negative result
FDA (Devices) · 2025-08-13